Pioneering studies have revealed that BRD4 is frequently overexpressed in multiple cancers including HNSCC [19, 38–40], and promotes tumorigenesis, cancer cell proliferation, metastasis and drug resistance by elevating the expression of cancer drivers [41–44]. The gene discussed is BRD4; the disease is head and neck squamous cell carcinoma.